We are live on !
Find out more
Banque Cantonale Vaudoise Portfolio holdings
AUM
$722M
Turnover
23.22%
1-Year Est. Return
30.45%
This Fund
S&P 500
This Quarter Est. Return
+16.26%
1 Year Est. Return
+30.45%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$722M
AUM Growth
-$1.94B
(-73%)
Cap. Flow
-$438M
Cap. Flow % of AUM
Cap. Flow %
-60.67%
Top 10 Holdings %
Top 10 Hldgs %
58.22%
Holding
956
New
82
Increased
260
Reduced
372
Closed
140
Avg Time Held
3.3
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$21.9M |
| 2 |
AstraZeneca
AZN
|
+$11.4M |
| 3 |
Amrize Ltd
AMRZ
|
+$10.6M |
| 4 |
Johnson & Johnson
JNJ
|
+$8.1M |
| 5 |
Walmart Inc
WMT
|
+$5.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$85.9M |
| 2 |
Amazon
AMZN
|
+$49.2M |
| 3 |
Applied Materials
AMAT
|
+$15.5M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$14.3M |
| 5 |
Advanced Micro Devices
AMD
|
+$13.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.44% |
| 2 | Healthcare | 20.15% |
| 3 | Communication Services | 15.97% |
| 4 | Industrials | 10.45% |
| 5 | Materials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
676
UiPath
PATH
$7.36B
| $139 | ﹤0.01% |
12,767
| – | – |
2025 Q3
3 quarters
|
|
677
iShares 0-1 Year Treasury Bond ETF
SHV
$23.5B
| $139 | ﹤0.01% |
1,257
+114
| +10% | +$12.6K |
2025 Q1
5 quarters
|
|
678
KraneShares CSI China Internet ETF
KWEB
$4.29B
| $137 | ﹤0.01% |
5,588
-569
| -9% | -$15.8K |
2020 Q3
23 quarters
|
|
679
State Street Financial Select Sector SPDR ETF
XLF
$51.9B
| $136 | ﹤0.01% |
2,533
| – | – |
2020 Q3
23 quarters
|
|
680
Standard Lithium
SLI
$353M
| $135 | ﹤0.01% |
49,300
| – | – |
2025 Q3
3 quarters
|
|
681
Grupo Aeroportuario del Pacifico
PAC
$13.2B
| $133 | ﹤0.01% |
+524
| New | +$129K |
2026 Q2
0 quarters
|
|
682
Loews
L
$22.9B
| $131 | ﹤0.01% |
1,161
| – | – |
2026 Q1
1 quarter
|
|
683
Vivmark Residential
VMRK
$48.8B
| $125 | ﹤0.01% |
+1,842
| New | +$119K |
2026 Q2
0 quarters
|
|
684
Markel Group
MKL
$23.2B
| $125 | ﹤0.01% |
64
+32
| +100% | +$59.8K |
2026 Q1
1 quarter
|
|
685
LATAM Airlines Group S.A.
LTM
$13.3B
| $125 | ﹤0.01% |
+2,150
| New | +$111K |
2026 Q2
0 quarters
|
|
686
Planet Labs
PL
$4.88B
| $124 | ﹤0.01% |
+3,751
| New | +$139K |
2026 Q2
0 quarters
|
|
687
iShares MSCI Indonesia ETF
EIDO
$367M
| $123 | ﹤0.01% |
+10,891
| New | +$152K |
2026 Q2
0 quarters
|
|
688
Teva Pharmaceutical Industries Limited
TEVA
$46B
| $123 | ﹤0.01% |
3,627
-1,506
| -29% | -$50.2K |
2020 Q3
23 quarters
|
|
689
iShares MSCI Mexico ETF
EWW
$1.48B
| $121 | ﹤0.01% |
1,604
-164
| -9% | -$12.7K |
2021 Q1
21 quarters
|
|
690
Royalty Pharma
RPRX
$28.4B
| $119 | ﹤0.01% |
2,120
| – | – |
2026 Q1
1 quarter
|
|
691
Hims & Hers Health
HIMS
$6.47B
| $118 | ﹤0.01% |
+3,400
| New | +$91.3K |
2026 Q2
0 quarters
|
|
692
Principal Financial Group
PFG
$23.2B
| $118 | ﹤0.01% |
+1,096
| New | +$111K |
2026 Q2
0 quarters
|
|
693
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.7B
| $113 | ﹤0.01% |
2,010
| – | – |
2025 Q1
5 quarters
|
|
694
iShares Core US Aggregate Bond ETF
AGG
$139B
| $109 | ﹤0.01% |
1,100
| – | – |
2023 Q2
12 quarters
|
|
695
iShares Core S&P Small-Cap ETF
IJR
$104B
| $109 | ﹤0.01% |
738
| – | – |
2021 Q2
20 quarters
|
|
696
Tradeweb Markets
TW
$25.9B
| $109 | ﹤0.01% |
+1,096
| New | +$119K |
2026 Q2
0 quarters
|
|
697
Steris
STE
$22.6B
| $108 | ﹤0.01% |
511
-2,048
| -80% | -$439K |
2026 Q1
1 quarter
|
|
698
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.1B
| $106 | ﹤0.01% |
902
| – | – |
2021 Q4
18 quarters
|
|
699
iShares 7-10 Year Treasury Bond ETF
IEF
$41.9B
| $105 | ﹤0.01% |
1,106
-93
| -8% | -$8.8K |
2022 Q3
15 quarters
|
|
700
Petrobras Class A
PBR.A
$152B
| $104 | ﹤0.01% |
+7,091
| New | +$125K |
2026 Q2
0 quarters
|
|
Similar funds
AO
Banque Cantonale Vaudoise's Q2 2026 Portfolio in Review
As of Q2 2026, Banque Cantonale Vaudoise held 956 positions worth $722M, down 73% from $2.66B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Banque Cantonale Vaudoise withdrew a net $438M in Q2 2026, closing 140 positions and reducing 372 holdings. Its most notable exit was Apple, an estimated $85.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 28% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Banque Cantonale Vaudoise opened a new position in AstraZeneca worth $11.3M.
- Banque Cantonale Vaudoise's largest Q2 2026 buy was AstraZeneca: 60,462 shares worth $11.3M.
- Banque Cantonale Vaudoise added most to Microsoft in Q2 2026, an estimated $21.9M increase.
- Banque Cantonale Vaudoise's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $14.3M.
- Banque Cantonale Vaudoise fully exited Apple in Q2 2026, selling an estimated $85.9M.
- Banque Cantonale Vaudoise's ten largest holdings make up 58% of its $722M portfolio in Q2 2026.
- Banque Cantonale Vaudoise opened 82 new positions and closed 140 in Q2 2026.
- Banque Cantonale Vaudoise's portfolio value fell 73% quarter-over-quarter to $722M.
Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.